Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amacathera, Argenx, Melt, Newamsterdam, Novo Nordisk, Painreform, Pasithea, Quralis, Sage, Uvax, Virion.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aelis, Biogen, Bridgebio, Brii, Cardiol, Chemomab, Eli Lilly, Esperion, Genethon, GSK, Immunitybio, Incyte, Merck, Newamsterdam, Nicox, Ocugen, Pliant, Protagonist, Regenxbio, Rocket, Silence, Thermosome, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Alnylam, Anthos, Arbutus, Bridgebio, Cybin, Eli Lilly, Intellia, Neurogene.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Aurinia, Eyenovia, Janssen, Levicept, Lixa, Omega, Osteal , Pacira.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Curium, Eli Lilly, Eupraxia, Gilead, GSK, Idrx, Immunic, ImmunoCure, Immutep, Inovio, Nuvectis, Sparian, AC Immune, Mediprint, Microbion, Nobias, X4.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptimmune, Aileron, Biorestorative, Creative Medical, Syros.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbisko, Astrazeneca, Code, Gilead, Gritstone, Hookipa, Insilico, Invivyd, Neurogene, Organogenesis, Quince, Spyre, Syndax, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Alligator, Aptevo , Beyondspring, Cantargia, Cerevance, Chimerix, Citius, Cue Biopharma, Enterobiotix, Everest Medicines, Marengo, Oncoinvent, Palleon, Relief, Replimune, Resolution, Storm, Tectonic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allogene, Amgen, Astrazeneca, Aulos, Aummune, Indaptus, Kineta, Nektar, Nimbus, Paratek, Radella.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascelia, Ascletis, Impact, Neurocrine, Springworks, Werewolf, Xilio.